CLVS stock forecast for 2023 – 2027

Are you interested in Clovis Oncology, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CLVS stock price in 2022-2027. Is CLVS a good long term stock? When should I take profit in Clovis Oncology stock? Buy or sell stock? Will CLVS stock price go up? What are analysts’ forecasts for CLVS stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CLVS stock returns are also predicted based on historical data.

According to our research, CLVS stock is a bad long-term investment. CLVS share price has been in a bear cycle for the past year. Clovis Oncology, Inc. stock trend is negative.

Clovis Oncology company info

Industry Biotechnology
Address 5500 Flatiron Parkway, Boulder, CO, 80301, United States
Website https://www.clovisoncology.com

Forecasting

52 Week High: 4.819 USD
52 Week Low: 0.00000101 USD
1 Year Forecast: 0.00000098 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 265.16M
52 Week Change: -5.954%
52 Week High: 11.1 USD
52 Week Low: 1.79 USD
Beta: 1.47369
50 Day Moving Average: 2.64
90 Day Moving Average: 3.042
200 Day Moving Average: 3.93
Resistance Level: 2.10573
Pivot Point: 2.018
Support Level: 1.97064
Enterprise Value: 829,910,144
Forward P/E: -1.38
Forward EPS: -1.4
Profit Margin: -191.62%
Shares Outstanding: 129,979,000
EBITDA: -3.70
Held Percent Institutions: 48.53%
PEG Ratio (5Y): -0.02
Trailing EPS: -2.781

Clovis Oncology stock forecasts for 2023-2027

DateOpen PriceClose PriceChange

Clovis Oncology Stock Forecast for 2023

January 2023 0 0 0%
February 2023 0 0 0%
March 2023 0 0 0%
April 2023 0 0 0%
May 2023 0 0 0%
June 2023 0 0 0%
July 2023 0 0 0%
August 2023 0 0 0%
September 2023 0 0 0%
October 2023 0 0 0%

Other companies stock forecasts